Replies to post #20596 on Endonovo Therapeutics Inc (ENDV)

[jdlamont]

As I said before-The increase in ejection fraction is of immense consequence, and the data have come through.
A NON INVASIVE treatment for cardiomyapathy by itself makes this a 3 dollar stock
However, Couple this with VASO's non invasive eecp treatment and you might find that 1 plus 1 =3!
People do not realize how many lives may be saved from premature death.
This is HHHHHHHHUUUUUUUUUUUUUUUUUIGGGGGGGEEEEEEE!!!!!!!!!!!